Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Allergy & Immunology

Edition

30-Second Takeaway

  • Occupational irritant exposure linked to fewer specific-IgE sensitizations in adults with adult-onset asthma.
  • Psychiatric diagnoses correlate with increased documented allergy counts in hospitalized adults.
  • One-strength accelerated HDM SCIT had comparable systemic safety to standard regimen in adolescents and adults.

Week ending May 2, 2026

Grand Rounds: Recent allergy/immunology evidence briefs

Occupational irritants associated with fewer sIgE sensitizations in adult-onset asthma

OCCUPATIONAL AND ENVIRONMENTAL MEDICINEApr 28, 2026

In 924 adults from the EGEA cohort, occupational irritant exposure was associated with a lower number of sIgE sensitizations in participants with adult-onset asthma (adjusted mean ratio 0.63, p≈0.06). Irritant exposure was linked to reduced house dust mite and pollen/animal predominant sensitization profiles (p=0.02 and p=0.06 respectively). No association was observed in participants without asthma or with childhood-onset asthma, and longitudinal analysis in 271 children showed no 'healthy hire' effect. Findings suggest exposure may influence sensitization through non-immunological mechanisms rather than preventing childhood sensitization.

Psychiatric diagnoses correlate with higher documented allergy counts

JOURNAL OF PSYCHIATRIC RESEARCHApr 26, 2026

Multicenter retrospective analysis of 71,725 adults found psychiatric diagnosis associated with more documented allergies (B = 0.74; R2 = 0.132; p < 0.001). Strongest associations were with somatic symptom, trauma-related, and obsessive-compulsive disorder categories. Authors highlight need for allergy verification in patients with psychiatric diagnoses to avoid mislabeling and unnecessary avoidance.

Accelerated one-strength HDM SCIT shows comparable systemic safety to standard regimen

FRONTIERS IN IMMUNOLOGYApr 27, 2026

In this randomized multicenter Chinese trial (n=211), systemic adverse drug reactions were similar between One-strength and Standard SCIT arms (7.4% vs 8.7%, p=0.72). Overall ADRs occurred in 57.3% of participants, mostly local and WAO grade 1–2, with no grade ≥3 events reported. Tolerability favored the One-strength regimen by patient and investigator ratings, but the open-label design may limit generalizability.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Confirm reported allergies in patients with psychiatric diagnoses before labeling or avoidance.
  • In adults with adult-onset asthma, consider non-immunologic mechanisms when evaluating irritant-exposed patients.
  • For tralokinumab-treated adolescents, routine laboratory monitoring is generally unnecessary absent clinical concern.